Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/027,353external-prioritypatent/US7858121B2/en
Application filed by Cima Labs IncfiledCriticalCima Labs Inc
Publication of TW200611696ApublicationCriticalpatent/TW200611696A/en
Fentanyl-containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than known oral formulation and have advantages in terms of reduced cost and reduced side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
TW094107150A2004-10-042005-03-09Effervescent oral fentanyl dosage form and methods of administering fentanyl
TW200611696A
(en)
Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
Pharmaceutical compositions and dosage forms for oral and sublingual tizanidine release and methods of sublingual or buccal administration of tizanidine